Impact of renal cell cancer histology on outcomes of microscopic positive surgical margins and implications on post-surgical follow-up. Patients who received solid organ transplants at Mayo Clinic ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the ...
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...
The ideal indication for NSS in the presence of a normal contralateral kidney is, therefore, the presence of an easily resectable, small (4 cm diameter or less), solitary, exophytic renal tumor ...
MTAP loss in primary kidney tumors: A comprehensive genomic profiling study. Multivariable Cox hazards model for the effect of preoperative β2 microglobulin on cancer-specific and overall survival in ...
All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear cell RCC with or without ipilimumab.
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback